The Claim
A biomarker panel consisting of senescence-associated proteins predicts mobility disability (defined as SPPB ≤7) with greater accuracy than prediction models based solely on age, sex, race, and BMI.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A set of biological markers related to cellular aging can more accurately identify people at risk of mobility problems than age, sex, race, or body mass index alone.
See the scientific wording
The biomarker panel of senescence-associated proteins predicts mobility disability (SPPB ≤7) with greater accuracy than age, sex, race, and BMI alone, suggesting these biomarkers provide additional information beyond demographic factors.
Older cells that have stopped dividing release a mix of harmful proteins into the blood, which cause muscle tissue to weaken, break down, and fail to repair. These proteins also trigger chronic inflammation that disrupts nerve signals to muscles and damages blood vessels, leading to slower walking, poor balance, and inability to stand or climb stairs.
What the research says
1 studyScientists found that measuring five specific proteins in the blood helps predict if an older person will have serious trouble walking or moving better than just using their age, sex, or weight alone. These proteins give extra useful info that demographics don't capture.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.